FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
19,809,063
Share change
-4,161,404
Total reported value
$5,749,187
Put/Call ratio
1.9%
Price per share
$0.29
Number of holders
43
Value change
-$2,025,532
Number of buys
16
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q3 2023

As of 30 Sep 2023, FORTRESS BIOTECH INC - COM (FBIO) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,809,063 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, Opaleye Management Inc., WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and WELLS FARGO & COMPANY/MN. This page lists 43 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.